Replimune Group, Inc. 4

Chief Accounting Officer Andrew Schwendenman sold 7,632 shares of Replimune Group, Inc. common stock at about $12.97 per share in a sell-to-cover tax transaction, retaining 99,425 shares afterward.

On August 10, 2026, Replimune Group, Inc. Chief Accounting Officer Andrew Schwendenman sold 7,632 shares of common stock at approximately $12.97 per share, in a transaction explicitly described as a mandatory “sell-to-cover” for tax withholding arising from the vesting of his performance-based restricted stock units, leaving him with ownership of 99,425 shares following the sale. This sale was executed under an irrevocable provision in the PSU award agreements and is characterized by the issuer as non-discretionary rather than a voluntary reduction of his economic exposure.

Filing Facts

CIK

1737953

Ticker

REPL

Form

4

Source Type

fda

Accession

0001104659-26-095003

Alert Tier

5